We are live on ! Find out more
MNTA

Momenta Pharmaceuticals, Inc.
MNTA

Delisted

MNTA was delisted on the 30th of September, 2020.

Back to rankings

0 hedge funds and large institutions have $0 invested in Momenta Pharmaceuticals, Inc. in 2020 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 211 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 211 → 0 (-211)

100% less funds holding in top 10

Funds holding in top 10: 16 → 0 (-16)

100% less capital invested

Capital invested by funds: $5.44B → $0 (-$5.44B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 211

Holders
–
Holders Change
-211
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-16
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
211
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$1.01B
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$685M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$622M
4
HI
HBK Investments
Texas
-$257M
5
State Street
State Street
Massachusetts
-$238M
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
– -$1.01B -19,179,344 Closed
Fidelity Investments
2
Fidelity Investments
Massachusetts
– -$685M -13,044,450 Closed
Vanguard Group
3
Vanguard Group
Pennsylvania
– -$622M -11,856,648 Closed
Millennium Management
4
Millennium Management
New York
– -$261K -4,966,005 Closed
HI
5
HBK Investments
Texas
– -$257M -4,900,000 Closed
State Street
6
State Street
Massachusetts
– -$238M -4,536,941 Closed
PCM
7
Pentwater Capital Management
Florida
– -$123M -2,348,200 Closed
Adage Capital Partners
8
Adage Capital Partners
Massachusetts
– -$117M -2,221,738 Closed
MF
9
Magnetar Financial
Illinois
– -$102M -1,946,428 Closed
Goldman Sachs
10
Goldman Sachs
New York
– -$84.5M -1,610,731 Closed
OP
11
Omni Partners
United Kingdom
– -$82M -1,561,837 Closed
JP Morgan Chase
12
JP Morgan Chase
New York
– -$76.7M -1,461,262 Closed
AAM
13
Alpine Associates Management
Florida
– -$75.4M -1,436,000 Closed
T. Rowe Price Associates
14
T. Rowe Price Associates
Maryland
– -$74.3M -1,415,865 Closed
Northern Trust
15
Northern Trust
Illinois
– -$73.9M -1,407,438 Closed
GF
16
Gabelli Funds
New York
– -$73.1M -1,392,732 Closed
GCL
17
Glazer Capital LLC
New York
– -$69.3M -1,320,748 Closed
Bank of New York Mellon
18
Bank of New York Mellon
New York
– -$65.6M -1,250,350 Closed
BCM
19
Beryl Capital Management
California
– -$60.6M -1,154,930 Closed
Norges Bank
20
Norges Bank
Norway
– -$59.5M -1,133,627 Closed
Balyasny Asset Management
21
Balyasny Asset Management
Illinois
– -$56.1M -1,069,013 Closed
VI
22
Versor Investments
New York
– -$49.9M -950,199 Closed
Bank of America
23
Bank of America
North Carolina
– -$47.9M -912,332 Closed
Geode Capital Management
24
Geode Capital Management
Massachusetts
– -$47.8M -910,419 Closed
WCMNY
25
Westchester Capital Management (New York)
New York
– -$44.1M -839,800 Closed
1
2 3 4 5

MNTA Hedge Fund Activity: Q4 2020 in Review

0 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Momenta Pharmaceuticals, Inc. (MNTA) for Q4 2020, worth a combined $0 — down 100% from $5.44B a quarter earlier.

Sellers outnumbered buyers: 211 funds closed out of MNTA and 0 opened new positions — a net loss of 211 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $1.01B sold.

  • 0 institutional investors held Momenta Pharmaceuticals, Inc. (MNTA) as of Q4 2020, down from 211 in Q3 2020.
  • Funds reported $0 of Momenta Pharmaceuticals, Inc. stock for Q4 2020, down 100% quarter-over-quarter.
  • 0 funds opened new Momenta Pharmaceuticals, Inc. positions in Q4 2020 and 211 closed out, a net change of -211 holders.
  • The largest Momenta Pharmaceuticals, Inc. seller in Q4 2020 was BlackRock, an estimated $1.01B sold.

Based on aggregated 13F filings for Q4 2020.